Melbourne And Boston Strike New Health Agreements
Premier Daniel Andrews today visited the Boston Children’s Hospital as part of his official US visit, announcing a new partnership with Victoria’s Royal Children’s Hospital in Melbourne.As two of the world’s leading children’s hospitals, the Boston and Royal…
Launch Vic Collaboration (July 2016)
July 2016 BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch…
Medical researchers warn Australia will lose scientists if funding is not boosted
The society representing Australian medical researchers says the country is at risk of losing high-value scientists to overseas research organisations unless funding for the sector is further increased.In 2015, 13.73 per cent of grant applications to the Federal Government’s National…
Retiring LBT Innovations CEO Lusia Guthrie Appointed Chair of Clever Culture Systems AG
Adelaide, Australia, 10 June 2016: The co-founder and Chief Executive of Australian laboratory automation company LBT Innovations Limited (LBT), Mrs Lusia Guthrie, has been appointed Chair of Clever Culture Systems AG (CCS) for a 2-year period from June…
Meeting with the Hon Wade Noonan MP
July 2016 BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has…
Two new strategies launched (July 2016)
July 2016 In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future…
Updated clinical trial data on CAVATAK™ tumour targeting and immune-activation presented at the American Society Clinical Oncology (ASCO) Annual Meeting
6 June 2016, Sydney, Australia: Viralytics Limited(ASX: VLA, OTC: VRACY) today announced that it has presented posters updating the results of the ongoing Phase 1 STORM/KEYNOTE 200 and the completed Phase 2 CALM clinical trials of Viralytics’ lead…
Robotic arm that could give amputees the sensation of touch being tested in Melbourne
A robotic arm that could result in amputees regaining their sense of touch and increased movement is the latest breakthrough for Melbourne researchers trying to develop prosthetic limbs that work “like normal”. Key points: Scientists want to send…
Gender Equality and Innovation (April 2016)
18 April 2016 It’s time to do things differently in Australia and be bolder in our commitment to diversity, says CEO of the BioMelbourne Network Dr Krystal Evans. SCIENCE MEETS BUSINESS Though Leadership Series. Click here for full…
Federal Budget: Scientists Push for More Research Funding
April 2016 Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest…
NISA Engagement and Impact Assessment Consultation Paper
June 2016 BioMelbourne Network welcomed the opportunity to contribute a submission in response to the National Innovation & Science Agenda (NISA) Engagement and Impact Assessment Consultation Paper. Research engagement and impact is a very important issue for BioMelbourne…
Response to Medical Technology and Pharmaceuticals Discussion Paper
September 2015 In September 2015, BioMelbourne Network welcomed the opportunity to contribute to the Medical Technology and Pharmaceuticals Discussion Paper produced by the Victorian Government’s Department of Economic Development, Jobs, Transport and Resources. This Paper formed part of…
